You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

R. Alan B. Ezekowitz

Co-Founder at Vividion Therapeutics, Inc.
Overview
Relationships
In The News
Paths
Education
Career History
Boards & Committees
Non-Profit Donations & Grants
Political Donations
Investments
Transactions

R. Alan B. Ezekowitz

Co-Founder at Vividion Therapeutics, Inc.

Overview

Age
64 (Born 1954)
Notable Companies
Vividion Therapeutics, Inc.

Abide Therapeutics, Inc.

Azanta Danmark A/S
Board Seats
14
Number of Relationships
This person is connected to 2,006 people.

Relationships See Details


Co-Founder at Cardinal Partners

Chairman, Department of Chemical Physiology at The Scripps Research Institute

Co-Founder at REPLIGEN Corp.

Co-Founder at Abide Therapeutics, Inc.

Chief Executive Officer at Kallyope, Inc.

Senior Vice President & Chief Innovation Officer at The Brigham & Women's Hospital, Inc.

Venture Partner at ARCH Venture Partners

Co-Founder at Cardinal Partners

Co-Founder at Vividion Therapeutics, Inc.

Chairman at Celgene Research & Development LLC
See 1,996 more listings with RelSci Professional.

In The News See More

PR Newswire
January 5, 2018
PR Newswire
November 28, 2017
PR Newswire
October 10, 2017
PR Newswire
September 18, 2017
PR Newswire
May 17, 2017
See full news coverage and complete stories with RelSci Professional.

Paths to R. Alan B. Ezekowitz

R. Alan B. Ezekowitz
You
Connections via Relationship Science
R. Alan B. Ezekowitz
Sync your contacts to see how you can connect with R. Alan B. Ezekowitz.

Educational Background

Doctor of Philosophy 
Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

Career History

Co-Founder
2014 - Current
Vividion Therapeutics, Inc. operates as a biotechnology company. It focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke and Alan Ezekowitz in 2014 and is headquartered in Princeton, NJ.
Co-Founder
2011 - Current
Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA.
Advisor
2011 - Current
Cardinal Partners focuses exclusively on healthcare investments including the life sciences, medical devices and healthcare information technology. The firm specializes in early-stage financing rounds, usually as the lead investor in the initial financing round of a growth company. Investments generally range from $6 million to $12 million per company. Cardinal Partners targets companies that: (1) operate in large or fast-growing markets (2) have a strong CEO, founder, team or scientist (3) possess a proprietary intellectual asset or novel technology and (4) have a well-defined business model.
Franchise Head, Bone, Respiratory, Immunology & Endocrine
2006 - 2011
Merck Research Laboratories, a subsidiary of Merck & Co., Inc., is a company headquartered in Boston, MA, that discovers, develops, and markets a broad range of human and animal health products.
Co-Founder
2000 - Prior
Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark.
Postdoctoral Fellowship, Division of Hematology & Oncology
Prior - 1995
Children's Hospital Corp. provides health care services that includes acupuncture, cardiac anesthesia, pediatric cataract, andrology program, atopic dermatits center, augmentative communication program, exercise physiology, endodontics, and many more. The company was founded in 1869 and is headquartered in Boston, MA.
Chief, Pediatric Services
1995 - Prior
Since 1811, Massachusetts General Hospital has been committed to delivering standard-setting medical care. Throughout the decades, the hospital has had a consistent commitment to advancing that care through pioneering research and educating future health care professionals. The third oldest general hospital in the United States and the oldest and largest hospital in New England, Mass General continues its tradition of excellence today. On July 17, 2012, Mass General was named America's best hospital by U. S. News & World Report based on our quality of care, patient safety and reputation in 16 different specialties. In 2008, Mass General was redesignated a Magnet hospital, the highest honor for nursing excellence awarded by the American Nurses Credentialing Center. World-Class Patient Care Our 907-bed medical center, located in the heart of Boston, offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery. We offer high-quality care and services in four health centers in the Boston area. The hospital also holds concurrent Level 1 verification for adult and pediatric trauma and burn care. Our five multidisciplinary care centers – known worldwide for innovations in cancer, digestive disorders, heart disease, transplantation and vascular medicine – unite specialists across the hospital to offer patients comprehensive, state-of-the-art medical care. In addition, through MassGeneral Hospital for Children, we provide a full range of pediatric health care services, from primary care to cutting-edge treatments of complex and rare disorders. A Research Powerhouse Mass General has long been a leader in successfully bridging innovative science with state-of-the-art clinical medicine. With an annual research budget of nearly $764 million, Mass General conducts the largest hospital-based research program in the United States - a program that spans more than 20 clinical departments and centers across the hospital. This funding drives discoveries and breakthroughs in basic and clinical research, which translate into new and better treatments that transform medical practice and patient care. Learn more about Mass General research. An Emphasis on Teaching Mass General is the original and largest teaching hospital of Harvard Medical School, where nearly all of our staff physicians serve on the faculty. Since the hospital’s founding, Mass General has been committed to training and mentoring the next generation of international leaders in science and medicine, providing a wealth of opportunities for physicians, nurses, allied health professionals, physical, occupational and speech and language therapists and other health professionals. These talented men and women, in turn, lend fresh and innovative perspective on how to treat and care for patients. See medical residency and fellowship opportunities at Mass General. Setting the Bar for Quality & Safety Safety, effectiveness, patient centeredness, timeliness, efficiency and equity – these six tenets established by the Institute of Medicine are the foundation of our approach to quality and safety. We measure our performance, set high goals and track our progress toward those goals. We compare ourselves against local and national benchmarks in key quality and safety areas to ensure we deliver the highest quality and safest care possible. Learn more about our quality and patient-safety programs. Reaching Out to the Community Our work has always been guided by the needs of patients and their families. Mass General partners with communities to build, improve and sustain health care delivery and increase the health and well-being of those who live and work and these communities. Read about how Mass General is making a difference locally and globally. At our main campus and four health centers in Charlestown, Chelsea, Revere and the North End, Mass General annually: Admits 47,000 inpatients Handles nearly 1.4 million outpatient visits Records 88,000 emergency room visits Performs 38,000 operations Delivers 3,600 babies Mass General is a founding member of Partners HealthCare, an integrated health care delivery system that includes the two founding academic medical centers, community hospitals, primary care and specialty physicians, specialty facilities, community health centers and other health-related entities. Our Mission Guided by the needs of our patients and their families, we aim to deliver the very best health care in a safe, compassionate environment; to advance that care through innovative research and education; and to improve the health and well-being of the diverse communities we serve
Chief of Pediatric Services
Prior
Partners HealthCare System, Inc. provides patient care, research, teaching and community services. It offers community and specialty hospitals, physician network, community health centers, home care and other health-related entities. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA.
Charles Wilder Professor of Pediatrics
Prior
Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.
Medical Trainee
Prior
The University of Cape Town (UCT) is a public research university located in Cape Town in the Western Cape province of South Africa. UCT was founded in 1829 as the South African College, and is the oldest university in South Africa and the second oldest extant university in Africa. The language of instruction is English.

Boards & Committees

Corporate Boards ▾
Member, Board of Directors
2017 - Current
Fulcrum Therapeutics, Inc. develops new medicines. It focus on unlocking gene control mechanisms to develop small molecule therapies. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie Lee and Bradley E. Bernstein and is headquartered in Cambridge, MA.
Non-Executive Director
2013 - Current
Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing in 1997 and is headquartered in Abingdon, the United Kingdom.
Member, Advisory Board
Current
Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA.
Director
Current
Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA.
Member, Therapeutic Advisory Board
Current
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler in 2005 and is headquartered in San Diego, CA.
Director
2012 - Prior
Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom.
Member, Board of Directors
Prior - 2009
Entomed SA discovers and develops novel medicines derived from insects. It discovers and develops new drugs derived from the biology of insects with a focus on their immune response. Entomed's technology is based on the scientific work carried out by Prof. Jules A. Hoffmann's world leading team in the CNRS Institute of Molecular and Cellular Biology (IBMC) in Strasbourg. The company was founded in 1999 and is headquartered in Illkirch-Graffenstaden, France.
Chairman, Scientific Advisory Board
Prior
Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration and wound healing. The company's products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Board Member
Prior
Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark.
Member, Board of Directors
Tenure Unconfirmed
Non-Profit Boards ▾
Chairman
Prior
Member, Board of Directors
Prior
Children's Hospital Corp. provides health care services that includes acupuncture, cardiac anesthesia, pediatric cataract, andrology program, atopic dermatits center, augmentative communication program, exercise physiology, endodontics, and many more. The company was founded in 1869 and is headquartered in Boston, MA.
Director
Prior
Partners HealthCare System, Inc. provides patient care, research, teaching and community services. It offers community and specialty hospitals, physician network, community health centers, home care and other health-related entities. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA.
Director
Prior
The Massachusetts General Physicians Organization (MGPO) is a multi-specialty medical group dedicated to excellence and innovation in patient care, teaching and research. The Massachusetts General Physicians Organization works in partnership with the Massachusetts General Hospital and in cooperation with Partners HealthCare

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$250 - $499
2006

Political Donations

$416
2011
$438
2010
$426
2009

Investments

Details Hidden
Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA.
Details Hidden
Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark.

Transactions

Details Hidden
Abide Therapeutics, Inc. raised money in a private placement transaction

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.